George Kaiser Family Foundation Invests $20.08 Million in Aspen Aerogels, Inc. $ASPN

George Kaiser Family Foundation acquired a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) during the 2nd quarter, Holdings Channel reports. The fund acquired 3,167,322 shares of the construction company’s stock, valued at approximately $20,081,000. Aspen Aerogels accounts for about 1.9% of George Kaiser Family Foundation’s portfolio, making the stock its 6th largest holding.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Raymond James Financial Inc. increased its stake in Aspen Aerogels by 6.8% in the second quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company’s stock valued at $157,000 after purchasing an additional 1,687 shares during the last quarter. Legal & General Group Plc boosted its stake in Aspen Aerogels by 3.6% in the 2nd quarter. Legal & General Group Plc now owns 67,130 shares of the construction company’s stock worth $397,000 after buying an additional 2,324 shares during the last quarter. Osaic Holdings Inc. boosted its stake in Aspen Aerogels by 29.1% in the 2nd quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company’s stock worth $63,000 after buying an additional 2,390 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in Aspen Aerogels by 12.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 24,671 shares of the construction company’s stock valued at $146,000 after buying an additional 2,656 shares during the period. Finally, Deutsche Bank AG grew its holdings in Aspen Aerogels by 1.3% in the 4th quarter. Deutsche Bank AG now owns 223,093 shares of the construction company’s stock valued at $631,000 after buying an additional 2,880 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

ASPN has been the subject of a number of research analyst reports. B. Riley Financial reaffirmed a “buy” rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Wall Street Zen cut shares of Aspen Aerogels from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. Roth Capital reaffirmed a “buy” rating and set a $7.75 price target on shares of Aspen Aerogels in a research report on Friday, August 7th. Finally, Barclays increased their price target on shares of Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a research note on Tuesday, August 11th. Four research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Aspen Aerogels has a consensus rating of “Hold” and a consensus price target of $5.94.

Aspen Aerogels Price Performance

ASPN stock opened at $5.21 on Friday. The stock has a 50-day moving average price of $5.50 and a two-hundred day moving average price of $4.58. Aspen Aerogels, Inc. has a 12-month low of $2.30 and a 12-month high of $9.35. The company has a current ratio of 2.52, a quick ratio of 2.24 and a debt-to-equity ratio of 0.36. The company has a market cap of $432.38 million, a PE ratio of -3.41 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Thursday, August 6th. The construction company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.01. The company had revenue of $49.85 million during the quarter, compared to analyst estimates of $42.42 million. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%.Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. As a group, research analysts predict that Aspen Aerogels, Inc. will post -0.69 EPS for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.